Kwang-Hyeon Liu

Title: Kwang-Hyeon Liu: Innovator in Pharmaceutical Composition

Introduction

Kwang-Hyeon Liu is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address vascular inflammation-related infectious diseases.

Latest Patents

Liu holds a patent for "2,5,6,7-tetrasubstituted thiazolo[4,5-b]pyridine derivatives and use thereof." This patent describes a pharmaceutical composition that includes a 2,5,6,7-tetrasubstituted thiazolo[4,5-b]pyridine derivative as an active ingredient. The composition is effective against vascular inflammation-related infectious diseases triggered by the activity of the HMGB1 protein. His research indicates that this pharmaceutical composition can enhance the survival rate in sepsis animal tests, making it a promising therapeutic agent for conditions related to vascular inflammation and infectious diseases, including sepsis.

Career Highlights

Kwang-Hyeon Liu is affiliated with the Kyungpook National University Industry-Academic Cooperation Foundation. His work focuses on innovative solutions in the pharmaceutical industry, contributing to advancements in medical treatments.

Collaborations

Liu has collaborated with notable colleagues, including Jong-Sup Bae and Sangkyu Lee, to further his research and development efforts in the pharmaceutical field.

Conclusion

Kwang-Hyeon Liu's innovative work in pharmaceutical compositions highlights his commitment to addressing critical health issues. His contributions are paving the way for new therapeutic options in the treatment of vascular inflammatory diseases and sepsis.